User profiles for Alison Holmes

Alison Holmes

- Verified email at imperial.ac.uk - Cited by 25850

Alison V Holmes

- Verified email at hitchcock.org - Cited by 1659

Understanding the mechanisms and drivers of antimicrobial resistance

AH Holmes, LSP Moore, A Sundsfjord, M Steinbakk… - The Lancet, 2016 - thelancet.com
To combat the threat to human health and biosecurity from antimicrobial resistance, an
understanding of its mechanisms and drivers is needed. Emergence of antimicrobial resistance in …

MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

…, X Zhao, J Christensen, T Kosaka, AJ Holmes… - science, 2007 - science.org
The epidermal growth factor receptor (EGFR) kinase inhibitors gefitinib and erlotinib are
effective treatments for lung cancers with EGFR activating mutations, but these tumors invariably …

Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing

…, M Gilchrist, G Satta, G Cooke, A Holmes - Clinical infectious …, 2020 - academic.oup.com
Background To explore and describe the current literature surrounding bacterial/fungal
coinfection in patients with coronavirus infection. Methods MEDLINE, EMBASE, and Web of …

Interventions to improve antibiotic prescribing practices for hospital inpatients

…, L Fenelon, IM Gould, A Holmes… - Cochrane database …, 2013 - cochranelibrary.com
Background The first publication of this review in Issue 3, 2005 included studies up to November
2003. This update adds studies to December 2006 and focuses on application of a new …

EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer

…, K Zejnullahu, C Murphy, E Lifshits, AJ Holmes… - Clinical cancer …, 2008 - AACR
Purpose: The EML4-ALK fusion gene has been detected in ∼7% of Japanese non-small cell
lung cancers (NSCLC). We determined the frequency of EML4-ALK in Caucasian NSCLC …

Behavior change strategies to influence antimicrobial prescribing in acute care: a systematic review

…, D Mullett, BD Franklin, A Holmes - Clinical Infectious …, 2011 - academic.oup.com
Background. Antimicrobial use in acute care is widely reported to be suboptimal.
Inappropriate use of antimicrobials is a major contributing factor to the emergence of multidrug …

Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non–small cell lung cancer patients treated with gefitinib or …

…, BY Yeap, LV Sequist, N Lindeman, AJ Holmes… - Clinical Cancer …, 2006 - AACR
Purpose: Somatic mutations in the epidermal growth factor receptor (EGFR) have been detected
in patients with non–small cell lung cancer (NSCLC) and are associated with sensitivity …

Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation

…, DG Bundy, AR Stark, DL Bogen, AV Holmes… - …, 2022 - publications.aap.org
Alison Volpe Holmes, MD, MPH, FAAP; Alison Volpe Holmes, MD, MPH, FAAP … Bogen,
Alison Volpe Holmes, Lori B. Feldman-Winter, Vinod K. Bhutani, Steven R. …

[HTML][HTML] Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum

…, J Carlet, S Cosgrove, H Goossens, A Holmes… - … resistance and infection …, 2013 - Springer
Antimicrobial resistance (AMR) is now a global threat. Its emergence rests on antimicrobial
overuse in humans and food-producing animals; globalization and suboptimal infection …

Hospital organisation, management, and structure for prevention of health-care-associated infection: a systematic review and expert consensus

W Zingg, A Holmes, M Dettenkofer… - The Lancet Infectious …, 2015 - thelancet.com
Despite control efforts, the burden of health-care-associated infections in Europe is high
and leads to around 37 000 deaths each year. We did a systematic review to identify crucial …